In vivo analysis exhibited higher drug concentrations in tumor site when EGFR peptide modified nanoparticles were used alongside the application of external magnetic field when compared to free drug and modified nanoparticles without magnetism [259]. This evidence concerns the gene EGFR and neoplasm.